Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Pharma Industry News Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval… byPallavi MadhirajuSeptember 29, 2024